CD274 and B-cell neoplasm: Clinico-pathological studies (91–93) have investigated the expression of PD-1, PD-L1, and PD-L2 in a large number of tumor-cells or tumor-microenvironment-cells (403, 899, and 702 biopsies, respectively) in various B-cell neoplasms, whether Hodgkin or non-Hodgkin lymphoma: Burkitt Lymphoma, DLBCL, Follicular Lymphoma (FL), Mantle Cell Lymphoma, Marginal Zone Lymphoma, Primary Mediastinal Lymphoma, and CLL).